133 related articles for article (PubMed ID: 6283283)
1. Concomitant changes of ACTH, beta-endorphin and N-terminal portion of pro-opiomelanocortin in rats.
Lis M; Larivière N; Maurice G; Julesz J; Seidah N; chrétien M
Life Sci; 1982 Apr; 30(14):1159-64. PubMed ID: 6283283
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a peptide similar to 16K fragment in man. Its relationship to ACTH.
Bertagna X; Girard F; Seurin D; Luton JP; Bricaire H; Mains RE; Eipper BA
J Clin Endocrinol Metab; 1980 Jul; 51(1):182-4. PubMed ID: 6247363
[TBL] [Abstract][Full Text] [Related]
3. Existence of a common precursor to ACTH and endorphin in the anterior and intermediate lobes of the rat pituitary.
Eipper BA; Mains RE
J Supramol Struct; 1978; 8(3):247-62. PubMed ID: 82677
[TBL] [Abstract][Full Text] [Related]
4. Molecular forms and anterior pituitary content of ACTH, beta-lipotropin, and beta-endorphin in diabetes insipidus di/di (Brattleboro) rats.
Allen RG; Crabbe JC; Stack J; Gaudette ND
Ann N Y Acad Sci; 1982; 394():574-9. PubMed ID: 6295233
[No Abstract] [Full Text] [Related]
5. Equine Cushing's disease: plasma immunoreactive proopiolipomelanocortin peptide and cortisol levels basally and in response to diagnostic tests.
Orth DN; Holscher MA; Wilson MG; Nicholson WE; Plue RE; Mount CD
Endocrinology; 1982 Apr; 110(4):1430-41. PubMed ID: 6277607
[No Abstract] [Full Text] [Related]
6. Biosynthesis and processing of pro-opiomelanocortin-derived peptides during fetal pituitary development.
Allen RG; Pintar JE; Stack J; Kendall JW
Dev Biol; 1984 Mar; 102(1):43-50. PubMed ID: 6321277
[TBL] [Abstract][Full Text] [Related]
7. Corticotropin releasing factor (CRF): effects on the release of pro-opiomelanocortin (POMC)-related peptides by human anterior pituitary cells in vitro.
Chan JS; Lu CL; Seidah NG; Chretien M
Endocrinology; 1982 Oct; 111(4):1388-90. PubMed ID: 6288359
[TBL] [Abstract][Full Text] [Related]
8. Differential control of the release of pro-opiomelanocortin-derived peptides from the pars intermedia of the rat pituitary. Response to serotonin.
Randle JC; Moor BC; Kraicer J
Neuroendocrinology; 1983 Aug; 37(2):131-40. PubMed ID: 6310431
[No Abstract] [Full Text] [Related]
9. Characterization of immunoreactive proopiomelanocortin-related peptides in rat testes.
Margioris AN; Liotta AS; Vaudry H; Bardin CW; Krieger DT
Endocrinology; 1983 Aug; 113(2):663-71. PubMed ID: 6191965
[TBL] [Abstract][Full Text] [Related]
10. Development of a radioimmunoassay for an amino-terminal peptide of pro-opiocortin containing the gamma-MSH region: measurement and characterization in human plasma.
Hope J; Ratter SJ; Estivariz FE; McLoughlin L; Lowry PJ
Clin Endocrinol (Oxf); 1981 Sep; 15(3):221-7. PubMed ID: 6273026
[TBL] [Abstract][Full Text] [Related]
11. Plasma immunoreactive proopiolipomelanocortin-derived peptides in patients with primary hyperaldosteronism, idiopathic hyperaldosteronism with bilateral adrenal hyperplasia, and dexamethasone-suppressible hyperaldosteronism.
Güllner HG; Nicholson WE; Gill JR; Orth DN
J Clin Endocrinol Metab; 1983 Apr; 56(4):853-5. PubMed ID: 6300169
[TBL] [Abstract][Full Text] [Related]
12. Dopamine-inhibited release of prolactin and intermediate lobe-POMC-peptides: different modulation by opioids.
Voigt KH; Frank D; Düker E; Martin R; Wuttke W
Life Sci; 1983; 33 Suppl 1():507-10. PubMed ID: 6319905
[TBL] [Abstract][Full Text] [Related]
13. Coordinate, equimolar secretion of smaller peptide products derived from pro-ACTH/endorphin by mouse pituitary tumor cells.
Mains RE; Eipper BA
J Cell Biol; 1981 Apr; 89(1):21-8. PubMed ID: 6262331
[TBL] [Abstract][Full Text] [Related]
14. A pituitary tumor producing high molecular weight adrenocorticotropin-related peptides: clinical and cell culture studies.
Fuller PJ; Lim AT; Barlow JW; White EL; Khalid BA; Copolov DL; Lolait S; Funder JW; Stockigt JR
J Clin Endocrinol Metab; 1984 Jan; 58(1):134-42. PubMed ID: 6315755
[TBL] [Abstract][Full Text] [Related]
15. Mineralocorticoid and glucocorticoid effects on 31,000- and 29,000-dalton proopiomelanocortin in rat anterior pituitary and neurointermediate lobe.
Khalid BA; Lim AT; Fraillon DR; Funder JW
J Clin Invest; 1982 Aug; 70(2):443-52. PubMed ID: 6284802
[TBL] [Abstract][Full Text] [Related]
16. Posttranslational processing of proadrenocorticotropin/endorphin-derived peptides during postnatal development in the rat pituitary.
Sato SM; Mains RE
Endocrinology; 1985 Aug; 117(2):773-86. PubMed ID: 2990862
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a radioimmunoassay for beta-endorphin-related peptides.
Vuolteenaho O; Leppäluoto J; Vakkuri O; Karppinen J; Höyhtyä M; Ling N
Acta Physiol Scand; 1981 Jul; 112(3):313-21. PubMed ID: 6270959
[TBL] [Abstract][Full Text] [Related]
18. Pituitary immunoreactive calcitonin-like material: lack of evidence for cross-reactivity with pro-opiomelanocortin.
Gagel RF; O'Briain DS; Voelkel EF; Wolfe HJ; DeLellis RA; Lee AK; Tashjian AH
Metabolism; 1983 Jul; 32(7):686-96. PubMed ID: 6191178
[TBL] [Abstract][Full Text] [Related]
19. Co-occurrence of immunoreactive corticotropin-like and alpha-melanotropin-like material in pituitary cells: differences between young and adult rats.
Schäfer M; Reiner J; Geis R; Voigt KH; Martin R
Neuropeptides; 1983 Jul; 3(5):387-97. PubMed ID: 6312363
[TBL] [Abstract][Full Text] [Related]
20. Postnatal development of beta-endorphin-related peptides in rat anterior and intermediate pituitary lobes: evidence for contrasting development of proopiomelanocortin processing.
Seizinger BR; Höllt V; Herz A
Endocrinology; 1984 Jul; 115(1):136-42. PubMed ID: 6329645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
